253 related articles for article (PubMed ID: 21182596)
21. [Roles of angiopoietin-like protein 2 (Angptl2) in chronic inflammation and atherosclerotic diseases].
Oike Y
Nihon Rinsho; 2011 Jan; 69(1):163-7. PubMed ID: 21226278
[TBL] [Abstract][Full Text] [Related]
22. Angiopoietins in malignancy.
Bach F; Uddin FJ; Burke D
Eur J Surg Oncol; 2007 Feb; 33(1):7-15. PubMed ID: 16962282
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis.
Ebert T; Bachmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
Metabolism; 2009 Apr; 58(4):547-51. PubMed ID: 19303977
[TBL] [Abstract][Full Text] [Related]
24. Structure and Function of Angiopoietin-like Protein 3 (ANGPTL3) in Atherosclerosis.
Lu X
Curr Med Chem; 2020; 27(31):5159-5174. PubMed ID: 31223079
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
26. Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Reutová H; Humenanská V; Petzel M; Kusnierová P; Vareka I; Vareková R; Stejskal P
Gen Physiol Biophys; 2008 Mar; 27(1):59-63. PubMed ID: 18436985
[TBL] [Abstract][Full Text] [Related]
27. The Roles of ANGPTL Families in Cancer Progression.
Endo M
J UOEH; 2019; 41(3):317-325. PubMed ID: 31548486
[TBL] [Abstract][Full Text] [Related]
28. Genetics and regulation of angiopoietin-like proteins 3 and 4.
Li C
Curr Opin Lipidol; 2006 Apr; 17(2):152-6. PubMed ID: 16531751
[TBL] [Abstract][Full Text] [Related]
29. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.
Després JP; Lemieux I; Bergeron J; Pibarot P; Mathieu P; Larose E; Rodés-Cabau J; Bertrand OF; Poirier P
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1039-49. PubMed ID: 18356555
[TBL] [Abstract][Full Text] [Related]
30. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.
Wisse BE
J Am Soc Nephrol; 2004 Nov; 15(11):2792-800. PubMed ID: 15504932
[TBL] [Abstract][Full Text] [Related]
31. Melatonin and the metabolic syndrome: a tool for effective therapy in obesity-associated abnormalities?
Nduhirabandi F; du Toit EF; Lochner A
Acta Physiol (Oxf); 2012 Jun; 205(2):209-23. PubMed ID: 22226301
[TBL] [Abstract][Full Text] [Related]
32. The role of the Angiopoietins in vascular morphogenesis.
Thomas M; Augustin HG
Angiogenesis; 2009; 12(2):125-37. PubMed ID: 19449109
[TBL] [Abstract][Full Text] [Related]
33. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
34. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor.
Shimamura M; Matsuda M; Ando Y; Koishi R; Yasumo H; Furukawa H; Shimomura I
Biochem Biophys Res Commun; 2004 Sep; 322(3):1080-5. PubMed ID: 15336575
[TBL] [Abstract][Full Text] [Related]
35. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
Smith AG; Muscat GE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
[TBL] [Abstract][Full Text] [Related]
36. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
Chan JC; Tong PC; Critchley JA
Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
[TBL] [Abstract][Full Text] [Related]
37. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
38. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
39. Angiopoietin-like protein 4: health effects, modulating agents and structure-function relationships.
Grootaert C; Van de Wiele T; Verstraete W; Bracke M; Vanhoecke B
Expert Rev Proteomics; 2012 Apr; 9(2):181-99. PubMed ID: 22462789
[TBL] [Abstract][Full Text] [Related]
40. Metabolic complications of obesity: inflated or inflamed?
Chandalia M; Abate N
J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
